Document is current

Article History

Received: 27 March 2021

Revised: 2 June 2021

Accepted: 3 June 2021

First Online: 11 June 2021

Declarations

:

: J. Havla reports grants for OCT research from the Friedrich-Baur-Stiftung and Merck, personal fees and non-financial support from Celgene, Merck, Alexion, Novartis, Roche, Santhera, Biogen, Heidelberg Engineering, Sanofi Genzyme and non-financial support of the Guthy-Jackson Charitable Foundation, all outside the submitted work. Y. Schultz, H. Zimmermann and A. Danek report no disclosures relevant to the manuscript. R. Hohlfeld received honoraria and grant support from Novartis, Sanofi, Biogen, Teva, Merck, JJ and Roche. T. Kümpfel has received travel expenses and personal compensation from Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis/Genzyme, Roche, and Biogen, as well as grant support from Bayer Schering AG, Novartis, and Chugai Pharma, all outside the submitted work.

: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

: The study was performed in accordance with the Helsinki II Declaration and approved by the ethics committee of the Ludwig-Maximilians-University, Munich, Medical Faculty (part of project no 280–16).

: All participants (or their legal representatives) gave written informed consent.

: We thank the patient reported here for the consent given to describe and publish the case.